BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27911389)

  • 1. Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System.
    Lee GH; Ahn KH; Yu IJ
    J Vis Exp; 2016 Nov; (117):. PubMed ID: 27911389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of information in nanomaterial safety data sheets and development of international standard for guidance on preparation of nanomaterial safety data sheets.
    Lee JH; Kuk WK; Kwon M; Lee JH; Lee KS; Yu IJ
    Nanotoxicology; 2013 May; 7(3):338-45. PubMed ID: 22263625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contamination and release of nanomaterials associated with the use of personal protective clothing.
    Tsai CS
    Ann Occup Hyg; 2015 May; 59(4):491-503. PubMed ID: 25582117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation exposure during spray application and subsequent sanding of a wood sealant containing zinc oxide nanoparticles.
    Cooper MR; West GH; Burrelli LG; Dresser D; Griffin KN; Segrave AM; Perrenoud J; Lippy BE
    J Occup Environ Hyg; 2017 Jul; 14(7):510-522. PubMed ID: 28406371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace.
    Engeman CD; Baumgartner L; Carr BM; Fish AM; Meyerhofer JD; Satterfield TA; Holden PA; Harthorn BH
    J Occup Environ Hyg; 2013; 10(9):487-95. PubMed ID: 23927041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials.
    Stone V; Johnston HJ; Balharry D; Gernand JM; Gulumian M
    Risk Anal; 2016 Aug; 36(8):1538-50. PubMed ID: 27285586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An appraisal of the published literature on the safety and toxicity of food-related nanomaterials.
    Card JW; Jonaitis TS; Tafazoli S; Magnuson BA
    Crit Rev Toxicol; 2011 Jan; 41(1):22-49. PubMed ID: 21077788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate and risks of nanomaterials in aquatic and terrestrial environments.
    Batley GE; Kirby JK; McLaughlin MJ
    Acc Chem Res; 2013 Mar; 46(3):854-62. PubMed ID: 22759090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Survey of Workplaces Handling and Manufacturing Nanomaterials, Exposure to and Health Effects of Nanomaterials, and Evaluation of Nanomaterial Safety Data Sheets.
    Kim J; Yu IJ
    Biomed Res Int; 2016; 2016():8389129. PubMed ID: 27556041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential for inhalation exposure to engineered nanoparticles from nanotechnology-based cosmetic powders.
    Nazarenko Y; Zhen H; Han T; Lioy PJ; Mainelis G
    Environ Health Perspect; 2012 Jun; 120(6):885-92. PubMed ID: 22394622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence in, and release of, nanomaterials from consumer products.
    Yang Y; Westerhoff P
    Adv Exp Med Biol; 2014; 811():1-17. PubMed ID: 24683024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs.
    Zolnik BS; Sadrieh N
    Adv Drug Deliv Rev; 2009 Jun; 61(6):422-7. PubMed ID: 19389437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research strategies for safety evaluation of nanomaterials, part VIII: International efforts to develop risk-based safety evaluations for nanomaterials.
    Thomas K; Aguar P; Kawasaki H; Morris J; Nakanishi J; Savage N
    Toxicol Sci; 2006 Jul; 92(1):23-32. PubMed ID: 16687392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific and Regulatory Considerations for Generic Complex Drug Products Containing Nanomaterials.
    Zheng N; Sun DD; Zou P; Jiang W
    AAPS J; 2017 May; 19(3):619-631. PubMed ID: 28116676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Has CDER Prepared for the Nano Revolution? A Review of Risk Assessment, Regulatory Research, and Guidance Activities.
    Tyner KM; Zheng N; Choi S; Xu X; Zou P; Jiang W; Guo C; Cruz CN
    AAPS J; 2017 Jul; 19(4):1071-1083. PubMed ID: 28421428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative assessment of nanomaterial definitions and safety evaluation considerations.
    Boverhof DR; Bramante CM; Butala JH; Clancy SF; Lafranconi M; West J; Gordon SC
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):137-50. PubMed ID: 26111608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure assessment approaches for engineered nanomaterials.
    Abbott LC; Maynard AD
    Risk Anal; 2010 Nov; 30(11):1634-44. PubMed ID: 20626687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomaterials: a challenge for toxicological risk assessment?
    Haase A; Tentschert J; Luch A
    Exp Suppl; 2012; 101():219-50. PubMed ID: 22945571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and characterization of nanomaterials released in low concentrations during multi-walled carbon nanotube spraying process in a cleanroom.
    Ji JH; Woo D; Lee SB; Kim T; Kim D; Kim JH; Bae GN
    Inhal Toxicol; 2013 Dec; 25(14):759-65. PubMed ID: 24304302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.